Show Summary Details

Quick Reference


either of two forms of erythropoietin produced by genetic engineering – e. alfa (Eprex) or e. beta (NeoRecormon) – administered by injection for treating anaemia associated with chronic renal failure or induced by chemotherapy.

Subjects: Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.